Dr. John C. Mavropoulos, MD, MPH, PhD

  • Sarasota, FL
  • Mohs-micrographic surgery physician
NPI1063737682PAC ID2860642519
Medicare services, 2024
1,464
Medicare patients, 2024
422
Part D claims, 2024
132
Publications
6
MIPS score, 2024
87
Practice address
3328 Bee Ridge Rd, Sarasota, FL 34239
Practice phone
Call (941) 926-2300
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Premier Dermatology

Sarasota, Florida

See all 11 affiliations

Find Dr. Mavropoulos' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John C. Mavropoulos is a mohs-micrographic surgery physician in Sarasota, Florida

Dr. Mavropoulos practices at Premier Dermatology in Sarasota, Florida.

Dr. Mavropoulos' NPI, 1063737682, was assigned on April 7, 2010. Dr. Mavropoulos graduated from Duke University School Of Medicine in 2010. Dr. Mavropoulos holds Florida license ME 124728.

NPI and contact details
Medicare PAC ID
2860642519
NPI enumeration date
April 7, 2010
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(941) 926-2300
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
42
Medical school graduation
2010

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John C. Mavropoulos practices at Premier Dermatology in Sarasota, Florida

Dr. Mavropoulos' primary practice is Premier Dermatology, at 3328 Bee Ridge Rd, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 926-2300.

  • Premier Dermatology
    3328 Bee Ridge Rd, Sarasota, FL 34239 · Sarasota CountyPhone(941) 926-2300

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. John C. Mavropoulos is affiliated with 6 sites of care and 5 medical groups

Dr. Mavropoulos' primary practice is Premier Dermatology in Sarasota, Florida. Dr. Mavropoulos is also affiliated with Altru Hospital. The medical group on file is MidState Skin Institute. Dmand AI also links Dr. Mavropoulos to 4 more group practices and clinics and 4 medical groups, each named with a free account.

See all 11 affiliations for Dr. Mavropoulos

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. John C. Mavropoulos' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mavropoulos practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Premier DermatologyAvailable with a free account
+5 more sites and 4 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Mavropoulos practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John C. Mavropoulos is one of 152 mohs-micrographic surgery physicians in Florida

Mohs-micrographic surgery is Dr. Mavropoulos' primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Mavropoulos is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Mavropoulos' licenses on file in 5 states: Florida, North Dakota, North Carolina, Pennsylvania and Virginia.

Specialties and state licenses

  • Mohs-micrographic surgery, FloridaPrimaryLicense ME 124728 · 2015 to 2027 · taxonomy 207ND0101X
  • North Dakota license2025 to 2026
  • North Carolina license2015 to 2025
  • Pennsylvania license2015 to 2024
  • Virginia license2010 to 2015

Clinical focus

Dmand AI lists cancerous skin growth removal and skin cyst among the conditions Dr. Mavropoulos treats.

Mohs-micrographic surgery physicians near Dr. Mavropoulos

Counts of mohs-micrographic surgery physicians with a Dmand AI profile, by place and practice. Each opens the list.

152mohs-micrographic surgery physicians in Florida
3mohs-micrographic surgery physicians in Sarasota

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John C. Mavropoulos billed Medicare for 1,464 services in 2024

CMS data shows 1,464 Medicare services from Dr. Mavropoulos across 18 procedure codes in 2024, for 422 Medicare patients. Medicare paid $511,543 for them. Every service was in an office.

Medicare services, 20241,464
Medicare patients422
Paid by Medicare$511,543
Procedure codes18

Dr. Mavropoulos' Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Surgery
2023: 1,6872024: 1,10235%
Other services
2023: 02024: 286
Office and hospital visits
2023: 502024: 7652%

Dr. Mavropoulos compared with the Florida median for mohs-micrographic surgery physicians, 2024

  • Dr. Mavropoulos
  • Florida median
Medicare services
1,464vs 2,67545% below
Medicare patients
422vs 65836% below
Part D claims
93vs 46680% below

Medians across 149 mohs-micrographic surgery physicians in Florida with Dmand AI profiles that report each measure.

Dr. Mavropoulos' most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mavropoulos

Need commercial claims for Dr. Mavropoulos?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mavropoulos and other mohs-micrographic surgery physicians in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John C. Mavropoulos treated 422 Medicare patients in 2024, average age 78

CMS counts 422 Medicare patients who saw Dr. Mavropoulos in 2024. The largest group is 75 to 84, with 185 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mavropoulos' median patient age at 77, with 38% women.

Medicare patients, 2024422
Average age78
Average risk score1.24

Dr. Mavropoulos' Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Mavropoulos' Medicare patients by sex, 2024

  • Women13933%
  • Men28367%

Chronic conditions among Dr. Mavropoulos' Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis48%
  4. Ischemic heart disease42%
  5. Atrial fibrillation28%
  6. Chronic kidney disease28%
  7. Diabetes23%
  8. Cancer20%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mavropoulos' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 77

Patient panel by sex, all payers

  • Women38%
  • Men62%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John C. Mavropoulos wrote 132 Medicare Part D claims in 2024

In 2024, Dr. Mavropoulos wrote 132 Medicare Part D claims for 121 patients. 98% of them were for generic drugs. CMS names the drug for 93 of them, across 2 drugs with 11 or more claims each, at $1,322 in total drug cost. In 2023, CMS named 190 claims across 5 drugs.

Part D claims, 2024132
Drugs named by CMS2
Total drug cost$1,322
Part D patients121

Dr. Mavropoulos' Part D claims by kind of drug, 2024

  • Generic129 claims98%
  • Brand-name and other3 claims2%

Dr. Mavropoulos' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mavropoulos' Part D claims, 2024

  • Antibiotics89%118 of 132 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1902024: 9351%

Drugs named by CMS: 2 in 2024, 5 in 2023.

See all prescribing by Dr. Mavropoulos

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John C. Mavropoulos scored 87 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mavropoulos for performance year 2024, reported as part of a group. Dr. Mavropoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,299 procedures of removal of skin cancer by Dr. Mavropoulos, more than 92% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Dr. Mavropoulos' MIPS scores, performance year 2024

  • 87of 100Final score
  • 73.3of 100Quality
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Dr. Mavropoulos ranks in Medicare procedure volume

Removal of skin cancer
92nd percentile1,299 procedures
Melanoma (skin cancer) excision
87th percentile51 procedures
Removal of skin lesions
67th percentile24 procedures
Skin biopsy
62nd percentile18 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find mohs-micrographic surgery physicians like Dr. Mavropoulos by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John C. Mavropoulos has 6 publications on record

Dmand AI links 6 papers to Dr. Mavropoulos, published from 2005 to 2016. The most frequent topics are Antibodies, Monoclonal.

Papers6
Years published2005 to 2016

Dr. Mavropoulos' papers by year, 2005 to 2016

Topics Dr. Mavropoulos writes about most

  • Antibodies, Monoclonal

Recent publications by Dr. Mavropoulos

See all 6 publications and co-authors

See who Dr. Mavropoulos researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mavropoulos works with, so you can find a warm path to the right mohs-micrographic surgery physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. John C. Mavropoulos received $3,950 in industry payments from 2016 to 2025

CMS Open Payments shows 142 general payments to Dr. Mavropoulos from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $978.

General payments to Dr. Mavropoulos by program year, 2016 to 2025

General payments to Dr. Mavropoulos by kind, 2016 to 2025

$3.9Kin total
  • Food and beverage$3,73595%
  • Consulting fees$2155%

Companies that paid Dr. Mavropoulos the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mavropoulos

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. John C. Mavropoulos graduated from Duke University School Of Medicine

Dr. Mavropoulos graduated from Duke University School Of Medicine in 2010.

  1. Medical schoolDuke University School Of Medicine
  2. Board certified in dermatologyAmerican Board of Dermatology

Source: Dmand AI Professional Profile Data

Dr. John C. Mavropoulos accepts plans from 18 insurance carriers

Dr. Mavropoulos is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Plan types Dr. Mavropoulos accepts, by number of carriers

  1. PPO12
  2. HMO10
  3. Medicare10
  4. EPO6
  5. POS6

Source: Dmand AI Insurance Network Data

Sources for Dr. John C. Mavropoulos's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John C. Mavropoulos

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John C. Mavropoulos' NPI number?

Dr. John C. Mavropoulos' NPI number is 1063737682. It was assigned on April 7, 2010, and it is active in the NPI Registry.

What kind of doctor is Dr. John C. Mavropoulos?

Dr. John C. Mavropoulos is a mohs-micrographic surgery physician in Sarasota, Florida. The primary specialty in the NPI Registry is MOHS-Micrographic Surgery Physician (taxonomy code 207ND0101X).

Where does Dr. John C. Mavropoulos practice?

Dr. Mavropoulos practices at 3328 Bee Ridge Rd, Sarasota, FL 34239. Dr. Mavropoulos' primary practice is Premier Dermatology in Sarasota, Florida. Dmand AI also links Dr. Mavropoulos to 4 group practices and clinics and 4 medical groups.

What is Dr. John C. Mavropoulos' office phone number?

The practice phone on file for Dr. Mavropoulos is (941) 926-2300.

What is Dr. John C. Mavropoulos' medical license number?

Dr. Mavropoulos holds Florida license ME 124728, one of the licenses on file in 5 states.

Which states has Dr. John C. Mavropoulos been licensed in?

Dmand AI has state licenses on file for Dr. Mavropoulos in Florida (2015 to 2027), North Dakota (2025 to 2026), North Carolina (2015 to 2025), Pennsylvania (2015 to 2024) and Virginia (2010 to 2015).

Which hospitals is Dr. John C. Mavropoulos affiliated with?

Dr. Mavropoulos is affiliated with Altru Hospital.

What medical group is Dr. John C. Mavropoulos part of?

Dr. Mavropoulos is linked to MidState Skin Institute. Dmand AI links Dr. Mavropoulos to 4 more medical groups.

Does Dr. John C. Mavropoulos accept Medicare?

Yes. CMS data shows Dr. Mavropoulos billed Medicare for 1,464 services in 2024, and Dr. Mavropoulos accepts Medicare assignment.

What is Dr. John C. Mavropoulos' MIPS score?

Dr. Mavropoulos' MIPS final score for performance year 2024 is 87 out of 100, reported as part of a group.

Show 9 more questionsShow fewer questions

How many Medicare patients does Dr. John C. Mavropoulos see?

CMS counts 422 Medicare patients who saw Dr. Mavropoulos in 2024, with an average age of 78.

Is Dr. John C. Mavropoulos board certified?

Yes. Dr. Mavropoulos is board certified in dermatology by the American Board of Dermatology.

What services does Dr. John C. Mavropoulos bill to Medicare?

In 2024, Dr. Mavropoulos' most billed Medicare services were surgery: skin and soft tissue (17311), surgery: skin and soft tissue (17312) and surgery: skin and soft tissue (13132).

Where did Dr. John C. Mavropoulos go to medical school?

Dr. Mavropoulos graduated from Duke University School Of Medicine in 2010.

What drugs does Dr. John C. Mavropoulos prescribe most?

In 2024 Medicare Part D data, Dr. Mavropoulos' most prescribed drugs by claims were Doxycycline Hyclate and Doxycycline Monohydrate.

Has Dr. John C. Mavropoulos received payments from drug or device companies?

CMS Open Payments shows $3,950 in general payments to Dr. Mavropoulos from 31 companies from 2016 to 2025. The largest total came from Abbvie Inc.

How long has Dr. John C. Mavropoulos been practicing?

Dr. Mavropoulos graduated from medical school in 2010, 16 years ago.

Does Dr. John C. Mavropoulos do research?

Dmand AI links 6 publications to Dr. Mavropoulos, published from 2005 to 2016.

What insurance does Dr. John C. Mavropoulos accept?

Dr. Mavropoulos is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to mohs-micrographic surgery practices?

See mohs-micrographic surgery physicians in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)